Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report

BACKGROUND: Nivolumab is an immune checkpoint inhibitor (ICI) and is used for the treatment of advanced non-small cell lung cancer (NSCLC). Several immune-mediated neurological adverse events associated with ICIs have been reported to date, such as Guillain-Barré syndrome. Nivolumab-associated neuro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Sakoh, Takashi, Kanzaki, Mami, Miyamoto, Atsushi, Mochizuki, Sayaka, Kakumoto, Toshiyuki, Sato, Kenichiro, Uesaka, Yoshikazu, Kishi, Kazuma
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6916037/
https://ncbi.nlm.nih.gov/pubmed/31842803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6444-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak